Our French company, with 100% made in France expertise, is a human-scale company that has been working with determination and unique expertise for more than 30 years, with the objective of saving lives. Our commitment has grown steadily since the design of our very first product: the vena cava filter. Exclusive innovation in 1991, recognized for its efficiency and reliability, our first permanent vena cava filter became optional in 2001.
Market leader in France, we are the only French manufacturer and distributor of vena cava filters. Our production sites are based in Bormes-les-Mimosas in the south of France and in Thyez in Haute-Savoie, a region renowned for its technological expertise.
Founded in 1997 by Alain NIGON, our company is today 25 people each working in their field of expertise, with attention to detail and a lot of mastery in the manufacturing of our medical devices. Medical devices (vena cava filters and removal and/or repositioning kits ALN), aimed at preventing pulmonary embolism, the 3rd cause of cardiovascular disease mortality worldwide.
Our expertise and French savoir faire, allows us to design and manufacture products in France for distribution worldwide. All our employees support common values, embodied in their daily lives.
And it is with the heart that everyone participates, in collaboration with our clients, public and private health facilities, to save lives around the world.
Our company has always served the medical profession and patients. Our vena cava filters and removal and/or repositioning kits ALN sold worldwide (through our direct sales force and network of trained distributors) , are the result of a great capacity for innovation and a keen sense of retail, which make them unique products of which we are proud.
Our core business is vena cava filtration, and our expertise in the field has built our reputation and notoriety among today’s market leaders, setting us apart from the rest of the market, both yesterday and today.
A constant capacity for innovation supported by monitoring developments in the healthcare world and a constant willingness to challenge ourselves. We never stay too content, in order to improve the existing one. Being a leader in the French market does not exempt us from a sustained attention to the evolution of our business worldwide.
We are on the move, and while we have created a unique product with the goal of saving lives, we remain attentive to potential improvements in the future. And this, in order to continue our technological advancement in the field, and to develop tomorrow new versions of our products, useful to the new needs related to venous thromboembolic disease.
ALN implants chirurgicaux lead with their heart and we have been able to combine and maintain since its creation a very high capacity for technological innovation, with human values embodied in each of our actions (internally, as in our commercial relations). Indeed, how can we work every day saving lives and not place the human at the center of our priorities and all our attention? Yes, we are proud of our purpose to “save lives” and how we put it into practice in our daily work.
ALN OATF filter launched
Launch of the 2in1 removal and/or repositioning kit
Launch of the ALN vena cava filter with hook
FDA approval. Creation of ALN Inc in the USA
CE marking ALN removal and/or repositioning kits (certification guaranteeing that the surgical device meets specific safety and clinical benefit requirements, set out in European regulations)
ALN filter becomes the first optional filter
CE mark of the jugular, brachial and femoral (venous) filters approach
Creation of ALN
Design of the permanent filter Vascor